Anticancer research
-
Anticancer research · Jan 2011
Randomized Controlled TrialRandomized phase II study of paclitaxel and carboplatin or vinorelbine in advanced non-small cell lung cancer.
A randomized phase II trial was conducted to determine if two non-platinum protocols are able to yield a similar efficacy and toxicity profile as compared to two platinum-based doublets in advanced non-small cell lung cancer (NSCLC). ⋯ The efficacy and toxicity profile of platinum-free combinations is comparable to that of platinum-based doublets.